CV Sciences, Inc. (CVSI) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

CV Sciences, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

CV Sciences, Inc. (CVSI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 93.84 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13

• CV Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 93.84M shares, a 93.91% increase year-over-year.
• CV Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 60.94M shares, a 2.86% increase year-over-year.
• CV Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 47.62M shares, a 7.37% increase year-over-year.
• CV Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 48.39M shares, a 9.12% increase year-over-year.
• CV Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 46.69M shares, a 5.35% increase from fiscal 2024.
• CV Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 44.32M shares, a 5.69% increase from fiscal 2023.
• CV Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 41.94M shares, a 12.33% increase from fiscal 2022.
• CV Sciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 37.33M shares, a 9.70% decline from fiscal 2021.